49 patents currently held
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Feb 2037. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2037
Next term end
24
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Dec 2040 · High confidence
Also notable
Ends Feb 2037 · High confidence
Also notable
Ends Nov 2039 · Medium confidence
Aspiration System with Accelerated Response
US 11,259,821
Cited by 100 later US patents, top 1% of utility patents granted in 2022 in our data. Protection runs to 2040.
Telescoping Neurovascular Catheter with Enlargeable Distal Opening
US 10,835,711
Cited by 120 later US patents, top 1% of utility patents granted in 2020 in our data. Protection runs to 2037.
Devices and Methods for Removing Obstructive Material from an Intravascular Site
US 11,395,665
Cited by 55 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 15, 2027The maintenance fee for Neurovascular Catheter with Enlargeable Distal End (US 10,441,745) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
- 1 fee due May 21, 2027The maintenance fee for Methods and Systems for Treating a Pulmonary Embolism (US 11,819,228) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 17, 2026
What they patent
The 5 largest of its 24 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Catheter Drive System for Supra-Aortic Access | 10 in force | to Jan 2045 |
| Methods and Systems for Advancing a Catheter to a Target Site | 9 in force | to Feb 2044 |
| Enhanced Flexibility Neurovascular Catheter | 8 in force | to Jun 2039 |
| Multi Catheter System with Integrated Fluidics Management | 2 in force | to Oct 2044 |
| Magnetic Coupling Through a Sterile Field Barrier | 1 in force | to May 2044 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,179,224 | Enhanced Flexibility Neurovascular Catheter with Tensile Support In force · High confidence | In force | High confidence | |
| US 10,183,145 | Enhanced Flexibility Neurovascular Catheter In force · High confidence | In force | High confidence | |
| US 10,183,146 | Method of Making an Enhanced Flexibility Neurovascular Catheter In force · High confidence | In force | High confidence | |
| US 10,183,147 | Neurovascular Catheter Extension Segment In force · High confidence | In force | High confidence | |
| US 10,441,745 | Neurovascular Catheter with Enlargeable Distal End In force · High confidence | In force | High confidence | |
| US 10,661,053 | Method of Pulsatile Neurovascular Aspiration with Telescoping Catheter In force · High confidence | In force | High confidence | |
| US 10,835,711 | Telescoping Neurovascular Catheter with Enlargeable Distal Opening In force · High confidence | In force | High confidence | |
| US 10,653,426 | Thromboresistant Coatings for Aneurysm Treatment Devices held by Incept, LLC In force · High confidence | In force | High confidence | |
| US 12,343,479 | Neurovascular Catheter In force · High confidence | In force | High confidence | |
| US 11,395,665 | Devices and Methods for Removing Obstructive Material from an Intravascular Site held by Incept, LLC In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 49: 10 patents in force now held by others · 68 applications pending · 3 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.